Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- MediBIC to Codevelop Anticancer Agent with Threshold Pharmaceuticals
February 7, 2005
- BUSINESS NEWS IN BRIEF
February 7, 2005
- Strong Demand for Microdose Clinical Studies
February 7, 2005
- BUSINESS SEMINAR
February 7, 2005
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
February 7, 2005
- WEBSITE NEWS
February 7, 2005
- Press Seminar
February 7, 2005
- PMDA Publishes Results of Survey on Social Expectations for R&D
January 31, 2005
-
January 31, 2005
- Use of Iressa in Japan to Continue as at Present: Korosho
January 31, 2005
- JSMI to Continue Raising Awareness of Self-medication in 2005
January 31, 2005
- Nippon Kayaku: Half-year Drug Sales Down 8.7% to \18.7 Bil.
January 31, 2005
- Sales of Foods for Health & Beauty Care Rose 9% in 2004: Fuji-Keizai
January 31, 2005
- Number of Births in 2004 Lowest Ever Recorded: Korosho
January 31, 2005
- Yamanouchi, RIKEN Elucidate Genetic Network of Biological Clock
January 31, 2005
- REGULATORY NEWS IN BRIEF
January 31, 2005
- DIAGNOSTIC NEWS IN BRIEF
January 31, 2005
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
January 31, 2005
- New Medical Devices GLP to Be Announced Shortly
January 31, 2005
- Meiji Seika to Reinforce Pharma Business in China
January 31, 2005
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…